Olin Announces Second Quarter 2026 Results

Olin posts a deeper loss and lower sales, merger with Huntsman still pending.

What the company is saying

Olin presents its second quarter 2026 results with a focus on adjusted EBITDA of $191.3 million and an explicit breakdown of segment sales and earnings. The company highlights the pending all-stock merger with Huntsman Corporation, describing it as a 'definitive agreement' and projecting completion in the first half of 2027, subject to regulatory and shareholder approvals. Management frames the quarter's performance by emphasizing segment-level improvements in Epoxy and Winchester, while acknowledging weaker Chlor Alkali Products and Vinyls results. The announcement details the resolution of legacy Shintech litigation, specifying $93 million paid and $100 million remaining. Forward-looking commentary is limited to a Q3 adjusted EBITDA forecast of $160–$200 million and expectations for operational recovery. The tone remains neutral and factual, with no attempt to minimize the increased net loss or declining sales.

What the data suggests

The reported net loss widened to ($13.3) million, or ($0.12) per diluted share, compared to a ($1.3) million loss a year earlier. Total sales fell slightly to $1,741.9 million from $1,758.3 million, with Chlor Alkali Products and Vinyls sales dropping sharply by $160 million year-over-year. Segment earnings in Chlor Alkali also declined, while Epoxy and Winchester segments posted both higher sales and improved earnings. Adjusted EBITDA rose to $191.3 million from $176.1 million, but this excludes $122.1 million in depreciation, $10.6 million in acquisition costs, and $10.5 million in restructuring charges. Net debt stands at approximately $2.85 billion, with a net debt to adjusted EBITDA ratio of 5.0 times, and available liquidity is $1.2 billion. The company paid $93 million to resolve litigation and expects to pay another $100 million in the second half. The Q3 EBITDA forecast signals little near-term improvement, with guidance in line with the current quarter. No cash flow or capex data is provided, and some claims, such as the merger agreement, lack direct numerical evidence.

Analysis

The announcement is factual and restrained, with no evidence of exaggerated tone or narrative inflation. Most claims are realised and supported by detailed numerical disclosures, including net loss, adjusted EBITDA, segment sales, and segment earnings. The only forward-looking statements are the Q3 2026 EBITDA forecast, the expected timing of the merger completion, and the remaining litigation payment, all of which are presented with appropriate caveats and timelines. There is no promotional language or overstatement of future benefits; the merger is described as subject to customary approvals, and the financial outlook is cautious. The company discloses a larger net loss and declining sales in key segments, which is negative, but does not attempt to frame these results in an unduly positive light. No large capital outlay is paired with long-dated, uncertain returns in this disclosure.

Risk flags

• ●Olin's net loss increased to ($13.3) million in Q2 2026 from ($1.3) million a year earlier, indicating deteriorating profitability and raising concerns about the company's ability to return to positive earnings without further restructuring or margin improvement.
• ●Net debt remains high at approximately $2.85 billion, with a net debt to adjusted EBITDA ratio of 5.0 times, which limits financial flexibility and increases vulnerability to further earnings declines or adverse market conditions.
• ●The pending merger with Huntsman is subject to regulatory and shareholder approvals, introducing execution risk and the possibility of delays or failure to close, which would undermine any anticipated merger-related benefits.
• ●The company faces continued cash outflows, including a remaining $100 million litigation payment expected in the second half of 2026, which will further pressure liquidity and may impact future investment or operational plans.

Bottom line

Olin's second quarter 2026 results show a deeper net loss and a modest decline in total sales, with particular weakness in the Chlor Alkali segment offset by improvements in Epoxy and Winchester. The company's high net debt and 5.0x leverage ratio leave little room for error if earnings remain under pressure. The merger with Huntsman, while potentially transformative, is at least a year away and subject to multiple approvals, so it offers no immediate relief. Litigation settlements continue to drain cash, and no evidence is provided of near-term profitability or cash flow improvement. For investors, the key takeaway is that Olin remains in a challenging financial position, with no quick fixes in sight and significant execution risks around the merger. Further disclosure on cash flow, capex, and post-merger integration plans would be necessary to reassess the outlook.

Announcement summary

(NYSE: OLN) Olin Corporation announced a second quarter 2026 net loss of ($13.3) million, or ($0.12) per diluted share. The company reported quarterly adjusted EBITDA of $191.3 million, excluding depreciation and amortization expense of $122.1 million, acquisition-related costs of $10.6 million, and restructuring charges of $10.5 million. Sales in the second quarter 2026 were $1,741.9 million, compared to $1,758.3 million in the second quarter 2025. Chlor Alkali Products and Vinyls sales for the second quarter 2026 were $819.5 million, Epoxy sales were $422.1 million, and Winchester sales were $500.3 million. Olin ended the second quarter 2026 with a cash balance of $177.4 million, net debt of approximately $2.85 billion, and available liquidity of approximately $1.2 billion. On June 16, 2026, Olin and Huntsman Corporation announced a definitive agreement to combine in an all-stock merger of equals to form OlinHuntsman Corporation, with completion expected in the first half of 2027. The company projects third quarter 2026 adjusted EBITDA to be in the range of $160 million to $200 million.

Disagree with this article?